NASDAQ
NRX Pharmaceuticals, Inc. (NRXP)
♥ 688 Thanks from members
NRx Pharmaceuticals (NRXP) demonstrates mixed market sentiment with a $152M-$179M market cap, driven by KETAFREE regulatory progress, HOPE subsidiary clinic revenues, and military-backed trial strategies, offset by Q2 earnings misses and going concern disclosures.